{
   "parameters" : {
      "stage" : "stage of disease",
      "id" : "subject identifier",
      "double.dt" : "doubling of initial bilirubin",
      "riskscore" : "the Mayo PBC risk score at entry",
      "tx.dt" : "date of liver transplant",
      "worsen.dt" : "worsening of symptoms by two stages",
      "varices.dt" : "appearance of esphogeal varices",
      "enceph.dt" : "appearance of encephalopathy",
      "entry.dt" : "date of entry into the study",
      "ascites.dt" : "appearance of ascites",
      "last.dt" : "date of last on-study visit",
      "hprogress.dt" : "date of histologic progression",
      "bili" : "bilirubin value at entry",
      "death.dt" : "date of death",
      "trt" : "treatment of 0=placebo, 1=UDCA"
   },
   "reference" : "This data set is used in the Therneau and Grambsh.  The udca1\ndata set contains the baseline variables along with the time until the\nfirst endpoint (any of death, transplant, ..., worsening).\nThe udca2 data set treats all of the endpoints as parallel\nevents and has a stratum for each.",
   "usage" : "udca\nudca2\ndata(udca, package=\"survival\")",
   "description" : "Description\nData from a trial of ursodeoxycholic acid (UDCA) in patients with primary\nbiliary cirrohosis (PBC).",
   "title" : "Data from a trial of usrodeoxycholic acid",
   "format" : "A data frame with 170 observations on the following 15 variables."
}
